Page 3 - Marshallh Woodworth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NeuroBo Pharmaceuticals Regains Compliance with Nasdaq Minimum Price Requirement

CAMBRIDGE, Mass., Jan. 9, 2024 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, announced that on January 8,.

United kingdomMarshallh woodworthMichael millerNeurobo pharmaceuticals incNasdaq stock marketNeurobo pharmaceuticalsRx communications groupPrnewswire neurobo pharmaceuticals incNasdaq listing ruleNasdaq capitalMetabolic dysfunction associated steatohepatitisPrivate securities litigation reform act

NeuroBo to Participate in Industry and Investor Conferences in January

CAMBRIDGE, Mass., Jan. 2, 2024 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced participation.

United kingdomMichael millerRobert homolkaMarshallh woodworthRx communications groupNeurobo pharmaceuticalsNeurobo pharmaceuticals incHyung heon kimChief executive officerSenior vice presidentClinical operationsBiotech showcaseActing chief financial officerMetabolic dysfunction associated steatohepatitis

NeuroBo Pharmaceuticals Submits IND Application to the FDA for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

CAMBRIDGE, Mass., Dec. 28, 2023 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has.

United kingdomMichael millerMarshallh woodworthDonga st coPrnewswire neurobo pharmaceuticals incNeurobo pharmaceuticalsRx communications groupNeurobo pharmaceuticals incDrug administrationInvestigational new drugHyung heon kimChief executive officerNon alcoholic steatohepatitisPrivate securities litigation reform act

NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split

NeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichael millerMarshallh woodworthCompany certificate of incorporationNeurobo pharmaceuticals incNeurobo pharmaceuticalsPrnewswire neurobo pharmaceuticals inc nasdaqDonga st coExchange commissionCompany common stockSplit adjusted basisCommon stockNasdaq capital marketNasdaq stock marketReverse stock splitInvestor relations

NeuroBo to Participate in Investor Conferences in December

BOSTON, Dec. 1, 2023 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases, today announced that Hyung.

United statesRobert homolkaMichael millerMarshallh woodworthPrnewswire neurobo pharmaceuticals incLife science virtual investor forumDonga st coNeurobo pharmaceuticalsRx communications groupNeurobo pharmaceuticals incHyung heon kimChief executive officerActing chief financial officerSenior vice presidentClinical operationsInvestor summit virtual